IP Library Granted Patent US 7,135,442
Granted Patent B2
US 7,135,442 · App. 10/044,373 · Granted Nov 14, 2006

Lens care product containing dexpanthenol

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,135,442
App. No.
10/044,373
Granted
Nov 14, 2006
Kind
B2
Abstract

The present invention relates to contact lens care product comprising dexpanthenol. The invention similarly relates to the usage of a contact lens care compositions of this kind for cleaning and optionally disinfecting contact lenses.

Claims (48)

1. Contact lens care composition comprising:

0.5 to 4 percent by weight dexpanthenol based on the total weight of the contact lens care composition;

one or more further constituents selected from the group consisting of buffer substances, substances that affect the tonicity, complexing agents and/or antimicrobial compounds; and

D-sorbitol.

2. Contact lens care composition according to claim 1 , comprising 0.8 to 6 percent by weight, of D-sorbitol, based on the total weight of the contact lens care composition.

3. Contact lens care composition according to claim 2 , comprising 1 to 3 percent by weight D-sorbitol, based on the total weight of the contact lens care composition.

4. Contact lens care composition comprising 0.5 to 4 percent by weight dexpanthenol based on the total weight of the contact lens care composition;

an antimicrobial agent which is a biguanide; and D-sorbitol.

5. Contact lens care composition according to claim 4 , comprising an aqueous solution comprising 0.5 to 4 percent by weight, of dexpanthenol, based on the total weight of the contact lens care composition.

6. Contact lens care composition according to claim 4 , which contains

dexpanthenol

5 to 20

g/l

NaCl or KCl

3 to 9

g/l

PHMB

0.0005 to 0.05

g/l

EDTA

0.1 to 2

g/l

as well as buffer substances and water, and has a pH value of 6 to 8.

7. Contact lens care composition according to claim 4 , further comprising D-sorbitol, one or more buffer substances, and a complexing agent.

8. Contact lens care composition according to claim 7 , which comprises

dexpanthenol

5 to 20

g/l

D-sorbit

10 to 30

g/l

NaCl or KCl

0 to 5

g/l

PHMB

0.0005 to 0.05

g/l

EDTA

0.1 to 2

g/l

as well as buffer substances and water, and has a pH value of 6 to 8.

9. Contact lens care composition according to claim 4 , which further comprises a surface-active substance.

10. Contact lens care composition according to claim 5 , comprising an aqueous solution comprising 1 to 3 percent by weight of dexpanthenol, based on the total weight of the contact lens care composition.

11. Method for cleaning and optionally disinfecting a contact lens, wherein a contact lens care composition according to claim 4 is brought into contact with a contact lens for a period of time that is sufficient to clean and optionally disinfect said lens.

12. Method for cleaning and optionally disinfecting a contact lens, wherein a contact lens care composition comprising dexpanthenol is brought into contact with a contact lens for a period of time that is sufficient to clean and optionally disinfect said lens.

13. Method for cleaning and optionally disinfecting a contact lens according to claim 12 , wherein the contact lens care composition further comprises D-sorbitol.

14. Method for cleaning and optionally disinfecting a contact lens according to claim 12 , wherein the contact lens care composition further comprises one or more further constituents selected from the group consisting of buffer substances, substances that affect the tonicity, complexing agents, and/or antimicrobial compounds.

15. Method for cleaning and optionally disinfecting a contact lens according to claim 13 , wherein the contact lens care composition further comprises one or more further constituents selected from the group consisting of buffer substances, substances that affect the tonicity, complexing agents, and/or antimicrobial compounds.

Assignments (2)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2006
From: SCHWIND, PETER; SCHERER, ANTON
To: NOVARTIS AG
Reel/Frame 018404/0390 →